deltatrials

COVID-19 Trials in Barcelona, Spain

Conditions / COVID-19 / Barcelona, Spain

Research into COVID-19 spans multiple therapeutic approaches and trial phases.

71 total trials for this combination

Showing top 10 of 71 trials

Trials

NCT ID Title Status Phase
NCT05780463 MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) COMPLETED PHASE3
NCT05605093 Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir) TERMINATED PHASE3
NCT04292899 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) COMPLETED PHASE3
NCT05780281 VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) COMPLETED PHASE3
NCT05822583 Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial COMPLETED PHASE4
NCT04401579 Adaptive COVID-19 Treatment Trial 2 (ACTT-2) COMPLETED PHASE3
NCT04292730 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment COMPLETED PHASE3
NCT05780424 BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) COMPLETED PHASE3
NCT04280705 Adaptive COVID-19 Treatment Trial (ACTT) COMPLETED PHASE3
NCT05780437 AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) COMPLETED PHASE3

Related Pages